首页> 外文期刊>Journal of vascular and interventional radiology: JVIR >Renal artery interventions during infrarenal endovascular aortic repair: a greater potential of subsequent failure?
【24h】

Renal artery interventions during infrarenal endovascular aortic repair: a greater potential of subsequent failure?

机译:肾下血管内主动脉修复期间的肾动脉干预:后续失败的可能性更大吗?

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

PURPOSE: To determine the anatomic and functional outcomes of renal artery interventions during endovascular aortic aneurysm repair (EVAR) and compare them with renal artery interventions without EVAR. MATERIALS AND METHODS: A renal artery revascularization database (1987-2007) was reviewed to identify patients who underwent renal intervention during EVAR and those who had an intervention in the absence of EVAR. Outcomes were analyzed with respect to patient comorbidities, renal anatomy and function, procedural events, and postoperative complications. RESULTS: A total of 413 patients (239 men; 58%) underwent 589 renal artery revascularizations (51 with EVAR and 362 without). Mean age was 70 years +/- 10. Mean follow-up was 3.5 years (range, 1-13 y). Primary indications for renal intervention were hypertension (63%) and elevated creatinine level (27%). The EVAR group was more likely to incur an increased creatinine level at 1 month after intervention (33% vs 18%; P = .007). Freedom from restenosis was similar (P = .501), but arterial occlusion rate was higher in the EVAR group (96% +/- 3% vs 100% +/- 10% cumulative patency at 3 y; P = .005). At 3 years, freedom from recurrent symptoms (P = .26), freedom from adverse renal events (P = .12), and survival (85% +/- 8% vs 75% +/- 2%; P = .83) were not significantly different. CONCLUSIONS: Renal artery revascularization during EVAR should be considered higher risk because of the high incidence of procedural complications, early functional injury, and early occlusion rates. However, the long-term sequelae and benefits of such a procedure are similar to those of a renal revascularization procedure in the absence of EVAR.
机译:目的:确定在血管内主动脉瘤修复(EVAR)期间肾动脉干预的解剖和功能结果,并将其与无EVAR的肾动脉干预进行比较。材料与方法:回顾了肾动脉血运重建数据库(1987-2007),以识别在EVAR期间接受肾脏干预的患者和在没有EVAR的情况下接受干预的患者。分析患者合并症,肾脏解剖和功能,手术事件和术后并发症的结局。结果:总共413例患者(239名男性; 58%)进行了589例肾动脉血运重建(其中51例使用EVAR,362例未使用)。平均年龄为70岁+/-10。平均随访时间为3.5年(范围1-13岁)。肾脏干预的主要指征是高血压(63%)和肌酐水平升高(27%)。 EVAR组在干预后1个月更有可能导致肌酐水平升高(33%对18%; P = .007)。无再狭窄的情况相似(P = .501),但EVAR组的动脉闭塞率较高(3 y时96%+/- 3%相对于100%+/- 10%的累积通畅率; P = .005)。在3年时,无复发症状(P = .26),无不良肾脏事件(P = .12)和生存率(85%+/- 8%vs 75%+/- 2%; P = .83 )没有显着差异。结论:由于手术并发症,早期功能性损伤和早期阻塞的发生率很高,因此应将EVAR期间的肾动脉血运重建视为较高风险。然而,这种方法的长期后遗症和益处与没有EVAR的情况下的肾脏血运重建术相似。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号